Open Access

Effects of leukemia inhibitory factor receptor on the adipogenic differentiation of human bone marrow mesenchymal stem cells

  • Authors:
    • Tao Wang
    • Ruiqiao Yan
    • Xiaoyuan Xu
    • Huan Yu
    • Jianfang Wu
    • Yaofang Yang
    • Weidong Li
  • View Affiliations

  • Published online on: April 8, 2019     https://doi.org/10.3892/mmr.2019.10140
  • Pages: 4719-4726
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Leukemia inhibitory factor (LIF) modulates various biological processes. Although previous studies have described the effects of LIF on adipocyte differentiation, the role of LIF receptor (LIFR) on adipocyte differentiation remains unclear. Using reverse transcription‑quantitative PCR (RT‑qPCR), LIFR expression was demonstrated to increase during adipogenic differentiation of human bone marrow mesenchymal stem cells (hMSCs), indicating that LIFR may be involved in this process. To further evaluate the association between LIFR and adipogenic differentiation, lentivirus‑mediated LIFR knockdown was performed in hMSCs. Cells were divided into two groups: Negative control group and LIFR‑knockdown group. During the adipogenic differentiation process, intracellular lipid accumulation was assessed with Oil Red O staining at various time points (days 3, 6 and 9). Additionally, the mRNA and protein expression levels of LIF, LIFR and three molecular indicators of adipogenesis, peroxisome proliferator‑activated receptor γ (PPARγ), CCAAT enhancer binding protein α (C/EBPα) and fatty acid binding protein 4 (FABP4/aP2), were assessed by RT‑qPCR and western blotting. The culture supernatant was collected to evaluate the concentration of LIF using ELISA. The present results suggested that LIFR expression progressively increased during adipogenic differentiation of hMSCs. Conversely, LIFR knockdown significantly suppressed this process. Additionally, PPARγ, C/EBPα and aP2 were inhibited following LIFR knockdown. In contrast with LIFR, the expression levels of LIF were significantly decreased after the initiation of adipogenic differentiation. Therefore, the expression levels of LIF and LIFR exhibited opposite trends. Collectively, the present results suggested that LIFR promoted adipogenic differentiation, whereas LIF may negatively regulate this process.

References

1 

Kopelman PG: Obesity as a medical problem. Nature. 404:635–643. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Kahn BB and Flier JS: Obesity and insulin resistance. J Clin Invest. 106:473–481. 2000. View Article : Google Scholar : PubMed/NCBI

3 

Keller M, Hopp L, Liu X, Wohland T, Rohde K, Cancello R, Klös M, Bacos K, Kern M, Eichelmann F, et al: Genome-wide DNA promoter methylation and transcriptome analysis in human adipose tissue unravels novel candidate genes for obesity. Mol Metab. 6:86–100. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Otto TC and Lane MD: Adipose development: From stem cell to adipocyte. Crit Rev Biochem Mol Biol. 40:229–242. 2005. View Article : Google Scholar : PubMed/NCBI

5 

Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI

6 

Helder MN, Knippenberg M, Klein-Nulend J and Wuisman PI: Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue Eng. 13:1799–1808. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Barry F, Boynton RE, Liu B and Murphy JM: Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components. Exp Cell Res. 268:189–200. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Arinzeh TL: Mesenchymal stem cells for bone repair: Preclinical studies and potential orthopedic applications. Foot Ankle Clin. 10:651–665. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Subash-Babu P and Alshatwi AA: Aloe-emodin inhibits adipocyte differentiation and maturation during in vitro human mesenchymal stem cell adipogenesis. J Biochem Mol Toxicol. 26:291–300. 2012. View Article : Google Scholar : PubMed/NCBI

10 

del Valle I, Rudloff S, Carles A, Li Y, Liszewska E, Vogt R and Kemler R: E-cadherin is required for the proper activation of the Lifr/Gp130 signaling pathway in mouse embryonic stem cells. Development. 140:1684–1692. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Pan W, Cain C, Yu Y and Kastin AJ: Receptor-mediated transport of LIF across blood-spinal cord barrier is upregulated after spinal cord injury. J Neuroimmunol. 174:119–125. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Plun-Favreau H, Perret D, Diveu C, Froger J, Chevalier S, Lelièvre E, Gascan H and Chabbert M: Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor. J Biol Chem. 278:27169–27179. 2003. View Article : Google Scholar : PubMed/NCBI

13 

White UA and Stephens JM: Neuropoietin activates STAT3 Independent of LIFR activation in adipocytes. Biochem Biophys Res Commun. 395:48–50. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Morton SD, Cadamuro M, Brivio S, Vismara M, Stecca T, Massani M, Bassi N, Furlanetto A, Joplin RE, Floreani A, et al: Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation. Oncotarget. 6:26052–26064. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Ikeda S, Itoh S, Yamamoto Y, Matsushita K, Naruse H and Hayashi M: Developmental stage-dependent effects of leukemia inhibitory factor on adipocyte differentiation of murine bone marrow stromal cells. Cell Biochem Biophys. 74:11–17. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Aubert J, Dessolin S, Belmonte N, Li M, McKenzie FR, Staccini L, Villageois P, Barhanin B, Vernallis A, Smith AG, et al: Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J Biol Chem. 274:24965–24972. 1999. View Article : Google Scholar : PubMed/NCBI

17 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

18 

Fernyhough ME, Hausman GJ, Guan LL, Okine E, Moore SS and Dodson MV: Mature adipocytes may be a source of stem cells for tissue engineering. Biochem Biophys Res Commun. 368:455–457. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Li X, Yang Y, Yan R, Xu X, Gao L, Mei J, Liu J, Wang X, Zhang J, Wu P, et al: miR-377-3p regulates adipogenic differentiation of human bone marrow mesenchymal stem cells by regulating LIFR. Mol Cell Biochem. 449:295–303. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Farmer SR: Transcriptional control of adipocyte formation. Cell Metab. 4:263–273. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Kudo M, Sugawara A, Uruno A, Takeuchi K and Ito S: Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/enhancer-binding protein delta during the early stage ofadipocyte differentiation. Endocrinology. 145:4948–4956. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Rosen ED, Walkey CJ, Puigserver P and Spiegelman BM: Transcriptional regulation of adipogenesis. Genes Dev. 14:1293–1307. 2000.PubMed/NCBI

23 

Zhang J, Huang Y, Shao H, Bi Q, Chen J and Ye Z: Grape seed procyanidin B2 inhibits adipogenesis of 3T3-L1 cells by targeting peroxisome proliferator-activated receptor γ with miR-483-5p involved mechanism. Biomed Pharmacother. 86:292–296. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Floyd ZE and Stephens JM: Controlling a master switch of adipocyte development and insulin sensitivity: Covalent modifications of PPARγ. Biochim Biophys Acta. 1822:1090–1095. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, et al: Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein FABP4. Nature. 447:959–965. 2007. View Article : Google Scholar : PubMed/NCBI

26 

Hwang CS, Mandrup S, MacDougald OA, Geiman DE and Lane MD: Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha. Proc Natl Acad Sci USA. 93:873–877. 1996. View Article : Google Scholar : PubMed/NCBI

27 

Oskowitz AZ, Lu J, Penfornis P, Ylostalo J, McBride J, Flemington EK, Prockop DJ and Pochampally R: Human multipotent stromal cells from bone marrow and microRNA: Regulation of differentiationand leukemia inhibitory factor expression. Proc Natl Acad Sci USA. 105:18372–18377. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Hogan JC and Stephens JM: Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. J Endocrinol. 185:485–496. 2005. View Article : Google Scholar : PubMed/NCBI

29 

Margioula-Siarkou C, Prapas Y, Petousis S, Milias S, Ravanos K, Kalogiannidis I, Mavromatidis G, Haitoglou C, Prapas N and Rousso D: LIF and LIF-R expression in the endometrium of fertile and infertile women: A prospective observational case-control study. Mol Med Rep. 13:4721–4728. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Li Y, Sun L, Zhao D, Ouyang J and Xiang M: Aberrant expression of leukemia inhibitory factor receptor (LIFR) and leukemia inhibitory factor (LIF) is associated with tubal pregnancy occurrence. Turk J Med Sci. 45:214–220. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Saito M, Asai Y, Imai K, Hiratoko S and Tanaka K: Connexin30.3 is expressed in mouse embryonic stem cells and is responsive to leukemia inhibitory factor. Sci Rep. 7:424032017. View Article : Google Scholar : PubMed/NCBI

32 

Cherepkova MY, Sineva GS and Pospelov VA: Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway. Cell Death Dis. 7:e20502016. View Article : Google Scholar : PubMed/NCBI

33 

Cheng HC, Liu SW, Li W, Zhao XF, Zhao X, Cheng M, Qiu L and Ma J: Arsenic trioxide regulates adipogenic and osteogenic differentiation in bone marrow MSCs of aplastic anemia patients through BMP4 gene. Acta Biochim Biophys Sin (Shanghai). 47:673–679. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Lecourt S, Vanneaux V, Leblanc T, Leroux G, Ternaux B, Benbunan M, Chomienne C, Baruchel A, Marolleau JP, Gluckman E, et al: Bone marrow microenvironment in fanconi anemia: A prospective functional study in a cohort of fanconi anemia patients. Stem Cells Dev. 19:203–208. 2010. View Article : Google Scholar : PubMed/NCBI

35 

Natesh K, Bhosale D, Desai A, Chandrika G, Pujari R, Jagtap J, Chugh A, Ranade D and Shastry P: Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling. Neoplasia. 17:225–237. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Wagener EM, Aurich M, Aparicio-Siegmund S, Floss DM, Garbers C, Breusing K, Rabe B, Schwanbeck R, Grötzinger J, Rose-John S and Scheller J: The amino acid exchange R28E in ciliaryneurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR). J Biol Chem. 289:18442–184450. 2014. View Article : Google Scholar : PubMed/NCBI

37 

Liu GX, Zhu JC, Chen XY, Zhu AZ, Liu CC, Lai Q and Chen ST: Inhibition of adipogenic differentiation of bone marrow mesenchymal stem cells by erythropoietin via activating ERK and P38 MAPK. Genet Mol Res. 14:6968–6977. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 19 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, T., Yan, R., Xu, X., Yu, H., Wu, J., Yang, Y., & Li, W. (2019). Effects of leukemia inhibitory factor receptor on the adipogenic differentiation of human bone marrow mesenchymal stem cells. Molecular Medicine Reports, 19, 4719-4726. https://doi.org/10.3892/mmr.2019.10140
MLA
Wang, T., Yan, R., Xu, X., Yu, H., Wu, J., Yang, Y., Li, W."Effects of leukemia inhibitory factor receptor on the adipogenic differentiation of human bone marrow mesenchymal stem cells". Molecular Medicine Reports 19.6 (2019): 4719-4726.
Chicago
Wang, T., Yan, R., Xu, X., Yu, H., Wu, J., Yang, Y., Li, W."Effects of leukemia inhibitory factor receptor on the adipogenic differentiation of human bone marrow mesenchymal stem cells". Molecular Medicine Reports 19, no. 6 (2019): 4719-4726. https://doi.org/10.3892/mmr.2019.10140